(Fighting against New Coronary Pneumonia) The Hong Kong Special Administrative Region Government has completed the "closed area forced inspection" for the 6th consecutive day without new confirmed cases
China News Service, Hong Kong, February 6th. At 9:30 a.m. on the 6th, Hong Kong Yuen Long and Ma On Shan designated "restricted areas" for mandatory new crown virus testing.
The SAR government visited a total of 1,328 households in two locations, and a total of more than 1,000 residents were tested. There were no new confirmed cases.
The Hong Kong Special Administrative Region Government quoted the "Prevention and Control of Diseases (Compulsory Testing for Certain Persons) Regulations" (Chapter 599J) on the evening of the 5th to make a restriction and testing announcement. Those who were restricted to Fu Lai Garden in Yuen Long and Heng Jiang Building, Heng On Village, Ma On Shan must stay that night At his premises and undergoing mandatory testing until the early morning of the 6th.
This is the sixth consecutive day that the Hong Kong Special Administrative Region government has conducted a "raid" all-Hong Kong "closed area" forced inspection.
As of 2 am today, about 576 residents in the designated "restricted area" in Yuen Long were tested, and about 457 residents in the designated "restricted area" in Ma On Shan were tested.
During the operation, the authorities sent personnel to visit about 1328 households in the two districts, 115 of which were unanswered, including some confirmed cases and households who may be quarantined. Some units may also be vacant.
The government also hopes that residents who have not answered the door will contact the government for inspection as soon as possible when they see the notice posted by the government, so as to eliminate the risk that the virus may have a chance to spread in the community.
In terms of vaccines, the Hong Kong Special Administrative Region Government stated on the evening of the 5th that the Department of Health of the Special Administrative Region Government has been actively following up with Kexing Holdings (Hong Kong). Wait for the third phase clinical test data.
(Finish)